Publications by authors named "John Fetting"

Claim this Profile
E
Evaluating DNA Methylation in Random Fine Needle Aspirates from the Breast to Inform Cancer Risk.
Kala Visvanathan, Ashley Cimino-Mathews, Mary Jo Fackler, Pritesh S Karia, Christopher J VandenBussche, John Fetting

Breast J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App.
Karen Lisa Smith, Hua-Ling Tsai, David Lim, Chenguang Wang, Raquel Nunes, John Fetting

JCO Oncol Pract· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes.
Elaine M Walsh, Neha Mangini, John Fetting, Deborah Armstrong, Isaac S Chan

Clin Breast Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation.
Karen Lisa Smith, Neha Verma, Amanda L Blackford, Jennifer Lehman, Kelly Westbrook, John Fetting

NPJ Breast Cancer· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized intervention involving family to improve communication in breast cancer care.
Jennifer L Wolff, Jennifer Aufill, Diane Echavarria, Amanda L Blackford, Roisin M Connolly, John H Fetting

NPJ Breast Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach.
Jennifer Y Sheng, Cesar A Santa-Maria, Neha Mangini, Haval Norman, Rima Couzi, John H Fetting

JCO Oncol Pract· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial.
Cesar A Santa-Maria, Janelle W Coughlin, Dipali Sharma, Mary Armanios, Amanda L Blackford, John Fetting

Clin Cancer Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic Germline Variants in Patients With Metastatic Breast Cancer.
Kelsey Stuttgen, Sarah Croessmann, John Fetting, Vered Stearns, Raquel Nunes

JAMA Oncol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sharing in care: engaging care partners in the care and communication of breast cancer patients.
Jennifer L Wolff, Jennifer Aufill, Diane Echavarria, JaAlah-Ai Heughan, Kimberley T Lee, John H Fetting

Breast Cancer Res Treat· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
Cesar A Santa-Maria, Aditya Bardia, Amanda L Blackford, Claire Snyder, Roisin M Connolly, John H Fetting

Breast Cancer Res Treat· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
Anya Litvak, Bhavina Batukbhai, Stuart D Russell, Hua-Ling Tsai, Gary L Rosner, John Fetting

Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational profiles of breast cancer metastases from a rapid autopsy series reveal multiple evolutionary trajectories.
Bracha Erlanger Avigdor, Ashley Cimino-Mathews, Angelo M DeMarzo, Jessica L Hicks, James Shin, John Fetting

JCI Insight· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study.
Roisin M Connolly, Huili Li, Rachel C Jankowitz, Zhe Zhang, Michelle A Rudek, John H Fetting

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer.
Hyun-Seok Kim, Christopher B Umbricht, Peter B Illei, Ashley Cimino-Mathews, Soonweng Cho, John H Fetting

J Clin Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer.
Roisin M Connolly, Jeffrey P Leal, Matthew P Goetz, Zhe Zhang, Xian C Zhou, John H Fetting

J Nucl Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III comparison of tamoxifen versus tamoxifen plus ovarian function suppression in premenopausal women with node-negative, hormone receptor-positive breast cancer (E-3193, INT-0142): a trial of the Eastern Cooperative Oncology Group.
Amye J Tevaarwerk, Molin Wang, Fengmin Zhao, John H Fetting, David Cella

J Clin Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer.
Gang Chen, Richa Gupta, Silvia Petrik, Marina Laiko, James M Leatherman, John Fetting

Cancer Immunol Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GATA3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas.
Ashley Cimino-Mathews, Andrea P Subhawong, Peter B Illei, Rajni Sharma, Marc K Halushka, John H Fetting

Hum Pathol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.
Michelle A Rudek, Roisin M Connolly, Janelle M Hoskins, Elizabeth Garrett-Mayer, Stacie C Jeter, John H Fetting

Breast Cancer Res Treat· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival in patients with metastatic recurrent breast cancer after adjuvant chemotherapy: little evidence of improvement over the past 30 years.
Amye J Tevaarwerk, Robert J Gray, Bryan P Schneider, Mary Lou Smith, Lynne I Wagner, John H Fetting

Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer.
Joseph A Sparano, Molin Wang, Fengmin Zhao, Vered Stearns, Silvana Martino, John Fetting

Cancer· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor expression is usually maintained in initial surgically resected breast cancer metastases but is often lost in end-stage metastases found at autopsy.
Ashley Cimino-Mathews, Jessica L Hicks, Peter B Illei, Marc K Halushka, John H Fetting

Hum Pathol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood.
Michaela J Higgins, Danijela Jelovac, Evan Barnathan, Brian Blair, Shannon Slater, John Fetting

Clin Cancer Res· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors.
Aatur D Singhi, Ashley Cimino-Mathews, Robert B Jenkins, Fusheng Lan, Stephanie R Fink, John H Fetting

Mod Pathol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer.
Michaela J Higgins, Tatiana M Prowell, Amanda L Blackford, Celia Byrne, Nagi F Khouri, John H Fetting

Breast Cancer Res Treat· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis